Tarsus Pharmaceuticals In... (TARS)

AI Score

Unlock

51.60

2.68 (5.48%)

At close: Apr 02, 2025, 3:59 PM

48.78

-5.46%

After-hours: Apr 02, 2025, 07:55 PM EDT

Tarsus Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	94.82M	224.95M	71.66M	171.33M	168.13M	57.95M	2.35M
Short-Term Investments	196.56M	2.5M	145.37M	483K	n/a	n/a	n/a
Long-Term Investments	3M	631K	371K	663K	n/a	n/a	n/a
Other Long-Term Assets	6.09M	1.51M	585K	463K	81K	6K	n/a
Receivables	48.06M	17.71M	3.58M	92K	20K	36K	4K
Inventory	2.62M	3.11M	4.76M	n/a	n/a	20K	n/a
Other Current Assets	14.65M	-1	n/a	4.04M	20K	n/a	20K
Total Current Assets	356.7M	256.13M	225.38M	175.95M	170.66M	58.03M	2.38M
Property-Plant & Equipment	2.87M	3.35M	1.53M	1.83M	1.24M	280K	6K
Goodwill & Intangibles	8.33M	3.87M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.29M	9.36M	2.49M	2.96M	1.32M	286K	6K
Total Assets	376.99M	265.49M	227.86M	178.91M	171.97M	58.32M	2.39M
Account Payables	27.74M	18.15M	5.5M	2.86M	2.24M	456K	175K
Deferred Revenue	n/a	n/a	n/a	697K	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	48.95M	5.14M	3.69M	55K	n/a	n/a	1K
Total Current Liabilities	80.61M	36.94M	15.43M	11.48M	5.39M	819K	179K
Long-Term Debt	71.84M	29.82M	19.43M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	233K	100K	114K	56K	63.4M	3.56M
Total Long-Term Liabilities	71.84M	31.57M	19.53M	699K	605K	63.5M	3.56M
Total Liabilities	152.46M	68.5M	34.96M	12.18M	5.99M	64.32M	3.74M
Total Debt	72.45M	31.73M	20.16M	1.89M	831K	164K	n/a
Common Stock	6K	5K	5K	4K	4K	2K	1K
Retained Earnings	-360.21M	-244.66M	-108.76M	-46.67M	-32.84M	-6.03M	-1.36M
Comprehensive Income	179K	-2K	-74K	n/a	-171.97M	-63.4M	-1K
Shareholders Equity	224.53M	196.99M	192.9M	166.73M	165.98M	-6M	-1.35M
Total Investments	199.56M	3.13M	145.74K	483K	n/a	n/a	n/a